<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02174133</url>
  </required_header>
  <id_info>
    <org_study_id>LVAD</org_study_id>
    <nct_id>NCT02174133</nct_id>
  </id_info>
  <brief_title>Impact of LVAD Implantation on Micro- and Macrovascular Function</brief_title>
  <acronym>LVAD</acronym>
  <official_title>Impact of LVAD Implantation on Micro- and Macrovascular Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinik für Kardiologie, Pneumologie und Angiologie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      End stage heart failure is characterized by a critical inability of the heart to meet the
      organism's blood demand even under resting conditions. Heart transplantation (HTx) is the
      established therapeutic approach in the treatment of end stage heart failure and still the
      gold standard treatment. Left ventricular assist devices (LVADs) are considered as a vital
      therapeutic option to temporarily or permanently assist the failing circulation. The
      hemodynamic vascular consequences of implanting LVADs have not been studied in detail. The
      aim of the study is to investigate the effect of LVAD implantation compared to heart
      transplant (HTx) on micro- and macrovascular function in patients with end stage heart
      failure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Macrovascular function measured by flow-mediated vasodilation (FMD)</measure>
    <time_frame>3 months after implantation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microvascular function assessed by non-invasive laser Doppler imaging</measure>
    <time_frame>3 months after implantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>microparticles determined by Flow Cytometry</measure>
    <time_frame>3 months after implantation</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>End Stage Heart Failure</condition>
  <arm_group>
    <arm_group_label>patients after HTX</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>patients after LVAD implantation</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with coronary heart disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients with end stage heart failure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients after HTX

          -  patients after LVAD implantation

          -  patients with stable coronary heart disease and normal systolic left ventricular
             function

          -  healthy volunteers

          -  written informed consent

        Exclusion Criteria:

          -  acute inflammation

          -  cardiac arrhythmia

          -  renal failure

          -  malignant disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Heiss, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology, Pulmonology and Vascular Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Cardiology, Pulmonology and Vascular Medicine Duesseldorf,</name>
      <address>
        <city>Duesseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2014</study_first_submitted>
  <study_first_submitted_qc>June 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2014</study_first_posted>
  <last_update_submitted>March 9, 2015</last_update_submitted>
  <last_update_submitted_qc>March 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Klinik für Kardiologie, Pneumologie und Angiologie</investigator_full_name>
    <investigator_title>Division of Cardiology, Pulmonary Diseases, Vascular Medicine</investigator_title>
  </responsible_party>
  <keyword>left ventricular assist device</keyword>
  <keyword>endothelial function</keyword>
  <keyword>microvascular perfusion</keyword>
  <keyword>microparticles</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

